Goldline Pharmaceutical IPO Key Details
Goldline Pharmaceutical IPO is priced at ₹41 to ₹43 per share ,
Each share has a face value of ₹10.
Goldline Pharmaceutical IPO is offering its shares to the public for the first time through an IPO on the stock exchanges BSE SME.
The total amount they aim to raise is 27,00,000 shares (agg. up to ₹12 Cr).
Goldline Pharmaceutical IPO open date is 12 May, 2026 and the IPO will close on 14 May, 2026.
|
Check Live IPO GMP List 👈
|
|
Check Live IPO Subscription List 👈
|
|
Check All IPO Allotment List 👈
|
| Live |
Goldline Pharmaceutical IPO Details
| IPO Category Type: | SME IPO |
| IPO Open: | 12 May, 2026 |
| IPO Close: | 14 May, 2026 |
| IPO Price Band: | ₹41 to ₹43 per share |
| Face Value: | ₹10 Per Equity Share |
| IPO Listing exchange: | BSE SME |
| IPO Issue Type: | Book Build Issue |
| IPO Size: | Approx 27,00,000 shares (agg. up to ₹12 Cr) |
| Fresh Issue: | Approx 25,62,000 shares (agg. up to ₹11 Cr) |
| Offer for Sale: | Approx [.] |
Goldline Pharmaceutical IPO GMP Today
Last Updated - 13 May, 2026 11:06 pm
Goldline Pharmaceutical IPO's GMP is ₹25 on 13 May, 2026 11:06 pm. If you add this to the IPO price, which is ₹43, you get an estimated listing price of ₹68. This means there's a potential gain of 58.1% per share.The GMP is updated daily.Keep an eye on daily updates to see how the IPO price is trending.
Goldline Pharmaceutical IPO's GMP is ₹25 on 13 May, 2026 11:06 pm. If you add this to the IPO price, which is ₹43, you get an estimated listing price of ₹68. This means there's a potential gain of 58.1% per share.The GMP is updated daily.Keep an eye on daily updates to see how the IPO price is trending.
| IPO Price : | 43 Rs |
| IPO GMP : | 25 Rs 👈 |
| Expected Listing Price : | 43+25 = 68 Rs |
| Expected IPO Gain %: | 58.1% 👈 |
| Rating : | ★★★★☆ |
| One Lot Shares: | 3000 |
| One Lot Price: | 1,29,000 Rs |
| One Lot Expected Listing: | 2,04,000 Rs |
| One Lot Expected Profit: | 75,000 Rs 👈 |
Goldline Pharmaceutical IPO Subscription Status
Last Updated - 13 May, 2026 5:13 pm
Subscription Day 2
Goldline Pharmaceutical IPO's subscription started on 12 May, 2026 and will close on 14 May, 2026. The retail quota is 33.33%, QIB is 47.11% and NII is 14.44%. Goldline Pharmaceutical IPO's subscriptions 100.14 times overall, including 1.31 times by Qualified institutional investors, 146.12 times by non-institutional investors, and 139.51 times by retail investors.
Subscription Day 2
Goldline Pharmaceutical IPO's subscription started on 12 May, 2026 and will close on 14 May, 2026. The retail quota is 33.33%, QIB is 47.11% and NII is 14.44%. Goldline Pharmaceutical IPO's subscriptions 100.14 times overall, including 1.31 times by Qualified institutional investors, 146.12 times by non-institutional investors, and 139.51 times by retail investors.
| QIB - Qualified Institutional Buyers: | 1.31x |
| NII - Non-Institutional Investors: | 146.12x |
| SNII - Small Non-Institutional Investors: - Bid below ₹10L | [.]x |
| BNII - Big Non-Institutional Investors: - Bid above ₹10L | [.]x |
| RII - Retail Individual Investor: | 139.51x |
| Total: | 100.14x 👈 |
Goldline Pharmaceutical IPO Allotment Status
Goldline Pharmaceutical IPO Allotment Status is to be decided on 15 May, 2026. The refund will be initiated on 18 May, 2026 and the shares will be credited to the Demat account on 18 May, 2026.
| IPO Registrar | Page Link |
|---|---|
| Bigshare Services Pvt Ltd | IPO Allotment Page |
| BSE | BSE IPO Allotment Page |
| NSE | NSE IPO Allotment Page |
| IPO Key | IPO Key Allotment Status Page |
Goldline Pharmaceutical IPO Allotment 15 May, 2026 after evening.
Goldline Pharmaceutical IPO Reservation
| Retail Quota: | 33.33% |
| QIB Quota: | 47.11% |
| NII Quota: | 14.44% |
| Employee Discount: | [.] |
Goldline Pharmaceutical IPO Prospectus
| DRHP Draft Prospectus: | [.] |
| RHP Draft Prospectus: | Continue Reading |
| Anchor Investors List: | [.] |
Goldline Pharmaceutical IPO Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| 1 | 3000 | ₹129000 |
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 6,000 | 258000 |
| Individual investors (Retail) (Max) | 2 | 6,000 | 258000 |
| S-HNI (Min) | 3 | 9,000 | 387000 |
| S-HNI (Max) | 7 | 21,000 | 903000 |
| B-HNI (Min) | 8 | 24,000 | 1032000 |
Goldline Pharmaceutical IPO Dates
| IPO Activity | Date |
|---|---|
| IPO Opens | 12 May, 2026 ✅ Completed |
| IPO Closes | 14 May, 2026 🕓 Upcoming |
| Allotment Date | 15 May, 2026 🕓 Upcoming |
| Refund Initiation | 18 May, 2026 🕓 Upcoming |
| Demat Credit | 18 May, 2026 🕓 Upcoming |
| Listing Date | 19 May, 2026 🕓 Upcoming |
Goldline Pharmaceutical Company Financial Report
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 27.40 | 26.28 | 22.93 | 19.39 |
| Total Income | 21.41 | 28.06 | 23.57 | 19.85 |
| Profit After Tax | 2.22 | 2.83 | 1.81 | 0.26 |
| EBITDA | 4.16 | 5.83 | 4.30 | 2.19 |
| NET Worth | 12.36 | 10.35 | 7.86 | 5.89 |
| Reserves and Surplus | 3.65 | 1.65 | 3.76 | 2.08 |
| Total Borrowing | 9.47 | 11.03 | 11.13 | 10.83 |
| Amount in ₹ Crore | ||||
Goldline Pharmaceutical Company Address
| Company | Goldline Pharmaceutical Ltd. |
|---|---|
| Address | 103, F-1, Leela Apartment, Shilpa HSG Society,Near Saptagiri Nagar, Shanidham,Narendra Nagar,, Nagpur, Maharashtra, 440015 |
| Phone | +91 712 2786666 |
| info@goldlinepharma.in | |
| Website | https://www.goldlinepharma.in/ |
Goldline Pharmaceutical IPO Registrar
| Company | Bigshare Services Pvt.Ltd. |
|---|---|
| Phone | +91-22-6263 8200 |
| ipo@bigshareonline.com | |
| Website | https://ipo.bigshareonline.com/IPO_Status.html |
Goldline Pharmaceutical IPO Lead Manager
- Cumulative Capital Pvt.Ltd.
Goldline Pharmaceutical IPO Key Performance Indicator ( KPI )
| KPI | Values |
|---|---|
| ROE | 21.02% |
| ROCE | 24.22% |
| Debt/Equity | 1.07 |
| RoNW | 17.99% |
| PAT Margin | 10.38% |
| EBITDA Margin | 19.41% |
Goldline Pharmaceutical IPO - FAQs
Q.What is Goldline Pharmaceutical IPO?
Ans.Goldline Pharmaceutical IPO is a SME IPO. The IPO is list on BSE SME.
Q.When Goldline Pharmaceutical IPO will open?
Ans.Goldline Pharmaceutical IPO is to open on 12 May, 2026 for Investors.
Q.What is Goldline Pharmaceutical IPO GMP Today?
Ans.Goldline Pharmaceutical IPO GMP Today is Check Here
Q.What is Goldline Pharmaceutical IPO Size?
Ans.Goldline Pharmaceutical IPO size is 27,00,000 shares (agg. up to ₹12 Cr).
Q.What is Goldline Pharmaceutical IPO Price Band?
Ans.Goldline Pharmaceutical IPO Price Band is ₹41 to ₹43 per share.
Q.What is the Goldline Pharmaceutical IPO Allotment Date?
Ans.Goldline Pharmaceutical IPO allotment date is 15 May, 2026.
Q.How to check Goldline Pharmaceutical IPO Allotment Status?
Ans.To check Goldline Pharmaceutical IPO allotment status Check Here
Q.What is the Goldline Pharmaceutical IPO Listing Date?
Ans.Goldline Pharmaceutical IPO listing date is 19 May, 2026. The IPO is to list on BSE SME.